Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neuralstem Inc (NASDAQ:CUR)

1.18
Delayed Data
As of Aug 18
 +0.02 / +1.72%
Today’s Change
0.99
Today|||52-Week Range
6.60
-66.80%
Year-to-Date
No recent news for Neuralstem Inc.

Today’s Trading

Previous close1.16
Today’s open1.17
Day’s range1.11 - 1.18
Volume89,753
Average volume (3 months)242,611
Market cap$14.3M
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+15.55%
Earnings growth (this year)-1,061.26%
Earnings growth (next 5 years)--
Revenue growth (last year)+55.96%
P/E ratioNM
Price/Sales1,825.89
Price/Book1.15

Competitors

 Today’s
change
Today’s
% change
RXIIRxi Pharmaceuticals ...-0.02-3.36%
GENEGenetic Technologies...-0.01-1.47%
NDRAENDRA Life Sciences ...0.000.00%
XTNTXtant Medical Holdin...+0.00+0.74%
Data as of 7:59pm ET, 08/18/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)-$6.50
Annual revenue (last year)$16.2K
Annual profit (last year)-$21.1M
Net profit margin-129,721.85%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, Chief Executive Officer &
CFO
Richard J. Daly
Chief Scientific Officer
Karl Y. Johe
Corporate headquarters
Germantown, Maryland

Forecasts